Skip to content

Multidrug Resistance After Trabeculectomy With Mitomycin C

Multidrug Resistance After Trabeculectomy With Mitomycin C

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00449631
Enrollment
30
Registered
2007-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2007-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Trabeculectomy

Keywords

Glaucoma, Drug Resistance, Multiple, Trabeculectomy

Brief summary

We investigate whether mitomycin C treatment during previous filtration surgery induces P-glycoprotein expression.

Detailed description

Despite the adjuvant use of mitomycin C during trabeculectomy, short-term and long-term failures still occur. We investigate whether mitomycin C treatment during previous trabeculectomy induces P-glycoprotein expression. Expression of P-glycoprotein is analysed in surgically removed Tenon tissue using immunohistochemistry.

Interventions

None listed

Sponsors

University of Cologne
Lead SponsorOTHER

Study design

Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
8 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* patients with planned trabeculectomy for elevated eye pressure * one third of patients without previous trabeculectomy * two thirds of patients with previous trabeculectomy (one third with and one third without the use of mitomycin C)

Exclusion criteria

* patients not requiring surgery * patients with planned surgery for elevated eye pressure other than trabeculectomy

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026